Safety and Efficacy of Oral Cannabis in Chronic Spine Pain

Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age21-84
SponsorUniversity of Colorado, Denver

About this trial

The overall objectives of this study are to investigate the efficacy of extended cannabis treatment to reduce patient exposure to prescription opioids through its use 1) as a non-opioid analgesic treatment, and 2) as a therapy for reducing high-dose opioid use in patients with chronic spine pain.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • THC/CBD
  • THC
  • Placebo

Treatment groups

157 Participants
are divided into 8 treatment groups

8

Treatment groups

See each treatment group below.

Sponsors and collaborators

University of Colorado, Denver

Lead sponsor

Institute of Cannabis Research

Collaborator